[Clinical evaluation of the hormonal effect of ovosiston in various dosages].
D000328:Adult; D000505:Alopecia / Q000139:chemically induced; D001835:Body Weight / Q000187:drug effects; D002715:Chlormadinone Acetate / Q000008:administration & dosage / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects*; D003864:Depression, Chemical; D007172:Erectile Dysfunction / Q000139:chemically induced; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008297:Male; D008599:Menstruation Disturbances / Q000139:chemically induced; D008656:Mestranol / Q000008:administration & dosage / Q000009:adverse effects; D008881:Migraine Disorders / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D009497:Neurotic Disorders / Q000139:chemically induced; D012871:Skin Diseases / Q000139:chemically induced; D013268:Stimulation, Chemical; D014652:Vascular Diseases / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D003276:Contraceptives, Oral; D002715:Chlormadinone Acetate; D008656:Mestranol
Klinische Einschätzung der hormonalen Wirksamkeit von Ovosiston in unterschiedlicher Dosierung.